From his parents’ basement to your medicine cabinet: Absci CEO endeavors to create biotech’s Apple Read more →

ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM Read more →

Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody Read more →